Healthcare Innovation

With new CEO Craig Mengert and backing from Altaris, Tegria is pivoting to an AI-first strategy, aiming to reshape healthcare tech modernization.

Dr. Bonnie Johnson's appointment as JAPA's book review editor signals a new era focused on bridging academic theory with real-world urban planning challenges.

With Bill S-228, Canada is criminalizing forced sterilization. It’s more than a new law; it’s a reckoning with a dark history and a test of reconciliation.

A rare endowed chair at a community hospital, backed by the powerful Boswell Foundation, positions Huntington Health and its new leader for a new era.

As Capricor presents its late-stage DMD drug and novel exosome platform, can it convince investors it has the key to both patient impact and market success?

Beyond shiny trophies, the Astra Play Awards are a strategic tool for independent retailers, revealing key trends in STEM, wellness, and the growing 'kidult' market.

A Canadian upstart is poised to unlock a massive, untreated market by moving glaucoma surgery from the OR to the office. This isn't just a new device; it's a strategic dismantling of a decades-old bottleneck.

Metropolitan Dermatology is the first in NJ to adopt Nevisense®, an AI-backed scanner for melanoma. Is this tech a true game-changer or one move in a complex market?

TelyRx just filled its millionth prescription, but the real story isn't the number. It's the 'operational innovation' of its cash-pay model that's disrupting healthcare.

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.

With its new CryoTherm Palm, Therabody bets on thermoregulation to boost athletic power. We analyze the science, the strategy, and what it means for the future of wellness tech.

Medtronic veteran Jesse Litwak joins ProVerum, a move signaling the BPH innovator is shifting from R&D to aggressive commercial scale-up with its new ProVee tech.

South Korea's Dong Bang Co Ltd is moving beyond commodity animal drugs, targeting high-barrier markets. Is its focus on proprietary tech a viable global strategy?

Insulet unveils new data for its Omnipod 6 and a fully closed-loop system, signaling a major strategic push into the vast, untapped type 2 diabetes market.

Agoda is selling serenity by promoting Asia's 'hidden' retreats. But as the wellness travel market booms, what is the true cost for these fragile destinations?

Ottawa's first national eye care strategy isn't just about health. It's a calculated investment in economic resilience and systemic stability for an aging nation.

A new alliance between General Fluidics and Invetech seeks to move lab testing from centralized facilities to the clinic, promising faster, more accessible care.

As Parker Seminars plans its 2026 Dallas event, it's about more than tradition. It's a strategic convergence of chiropractic, neuroscience, and business.

Florida Southern College secures a rare 10-year nursing accreditation, signaling a critical boost for a state grappling with a persistent nursing shortage.

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.